These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22913327)

  • 21. Bone scintigraphy for early detection of transthyretin cardiac amyloidosis.
    Ikram A
    J Pak Med Assoc; 2016 Aug; 66(8):1045. PubMed ID: 27524550
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.
    Treglia G; Glaudemans AWJM; Bertagna F; Hazenberg BPC; Erba PA; Giubbini R; Ceriani L; Prior JO; Giovanella L; Slart RHJA
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1945-1955. PubMed ID: 29687207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of screening biopsies in light-chain (AL) and transthyretin (ATTR) amyloidosis.
    Cohen OC; Sharpley F; Gilbertson JA; Wechalekar AD; Sachchithanantham S; Mahmood S; Whelan CJ; Martinez-Naharro A; Fontana M; Lachmann HJ; Hawkins PN; Gillmore JD
    Eur J Haematol; 2020 Sep; 105(3):352-356. PubMed ID: 32495369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating cancer risk from
    Einstein AJ; Shuryak I; Castaño A; Mintz A; Maurer MS; Bokhari S
    J Nucl Cardiol; 2020 Feb; 27(1):215-224. PubMed ID: 29850972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cardiology fellow's take-home points from ASNC's Webinar: Cases in Tc 99m-PYP evaluation of ATTR cardiac amyloidosis - interpretation and reporting.
    Shetty M
    J Nucl Cardiol; 2021 Apr; 28(2):604-609. PubMed ID: 33655447
    [No Abstract]   [Full Text] [Related]  

  • 26. Imaging in systemic amyloidosis.
    Sachchithanantham S; Wechalekar AD
    Br Med Bull; 2013; 107():41-56. PubMed ID: 23896486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear imaging modalities for cardiac amyloidosis.
    Bokhari S; Shahzad R; Castaño A; Maurer MS
    J Nucl Cardiol; 2014 Feb; 21(1):175-84. PubMed ID: 24162886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear tracers for transthyretin cardiac amyloidosis: time to bone up?
    Ruberg FL; Miller EJ
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):162-4. PubMed ID: 23512778
    [No Abstract]   [Full Text] [Related]  

  • 29. Radionuclide Imaging of Cardiac Amyloidosis.
    Joseph V; Julien HM; Bravo PE
    PET Clin; 2021 Apr; 16(2):285-293. PubMed ID: 33589384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A potential pitfall in the use of
    Murray CSG; Moadel RM; Tauras JM; Zamora E; Travin MI
    J Nucl Cardiol; 2021 Oct; 28(5):2395-2398. PubMed ID: 32449000
    [No Abstract]   [Full Text] [Related]  

  • 31. Can Nuclear Imaging Techniques Predict Patient Outcome and Guide Medical Management in Hereditary Transthyretin Cardiac Amyloidosis?
    Algalarrondo V; Piekarski E; Eliahou L; Le Guludec D; Slama MS; Rouzet F
    Curr Cardiol Rep; 2018 Mar; 20(5):33. PubMed ID: 29574587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical diversity, diagnosis and treatment of hereditary amyloid neuropathy].
    Sekijima Y
    Rinsho Shinkeigaku; 2014; 54(12):953-6. PubMed ID: 25672679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of Single-Photon Emission Computed Tomography/Computed Tomography Fusion Imaging With
    Tsuda N; Shiraishi S; Oda S; Ogasawara K; Sakamoto F; Tomiguchi S; Fujisue K; Takashio S; Izumiya Y; Tsujita K; Ando Y; Yamashita Y
    Circ J; 2018 Jun; 82(7):1970-1971. PubMed ID: 29199249
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnosis and monitoring of amyloidosis.
    Hawkins PN
    Baillieres Clin Rheumatol; 1994 Aug; 8(3):635-59. PubMed ID: 7954867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac microcalcifications in transthyretin (ATTR) amyloidosis.
    Thelander U; Westermark GT; Antoni G; Estrada S; Zancanaro A; Ihse E; Westermark P
    Int J Cardiol; 2022 Apr; 352():84-91. PubMed ID: 35077727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of peptide p5 and serum amyloid P component for imaging AA amyloid in mice using dual-isotope SPECT.
    Wall JS; Richey T; Williams A; Stuckey A; Osborne D; Martin E; Kennel SJ
    Mol Imaging Biol; 2012 Aug; 14(4):402-7. PubMed ID: 22042488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interpreting technetium-99m pyrophosphate cardiac scans to diagnose transthyretin cardiac amyloidosis: Need for due diligence.
    Butera B; Klingler D; Mccord JK; Ananthasubramaniam K
    J Nucl Cardiol; 2021 Aug; 28(4):1798-1801. PubMed ID: 32390109
    [No Abstract]   [Full Text] [Related]  

  • 40. Transthyretin Cardiac Amyloidosis in Older Americans.
    Brunjes DL; Castano A; Clemons A; Rubin J; Maurer MS
    J Card Fail; 2016 Dec; 22(12):996-1003. PubMed ID: 27769906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.